Fingolimod targeting protein phosphatase 2A differently affects IL‐33 induced IL‐2 and IFN‐γ production in CD8+ lymphocytes
Open Access
- 18 December 2015
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 46 (4) , 941-951
Abstract
Multiple sclerosis patients are treated with fingolimod (FTY720), a prodrug that acts as an immune modulator. FTY720 is first phosphorylated to FTY720‐P and then internalizes sphingosine‐1‐phosphate receptors, preventing lymphocyte sequestration. IL‐33 is released from necrotic endothelial cells and contributes to MS severity by coactivating T cells. Herein we analyzed the influence of FTY720, FTY720‐P, and S1P on IL‐33 induced formation of IL‐2 and IFN‐γ, by using IL‐33 receptor overexpressing EL4 cells, primary CD8+ T cells, and splenocytes. EL4‐ST2 cells released IL‐2 after IL‐33 stimulation that was inhibited dose‐dependently by FTY720‐P but not FTY720. In this system, S1P increased IL‐2, and accordingly, inhibition of S1P producing sphingosine kinases diminished IL‐2 release. In primary CD8+ T cells and splenocytes IL‐33/IL‐12 stimulation induced IFN‐γ, which was prevented by FTY720 but not FTY720‐P, independently from intracellular phosphorylation. The inhibition of IFN‐γ by nonphosphorylated FTY720 was mediated via the SET/protein phosphatase 2A (PP2A) pathway, since a SET peptide antagonist also prevented IFN‐γ formation and the inhibition of IFN‐γ by FTY720 was reversible by a PP2A inhibitor. While our findings directly improve the understanding of FTY720 therapy in MS, they could also contribute to side effects of FTY720 treatment, like progressive multifocal leukoencephalopathy, caused by an insufficient immune response to a viral infection.Keywords
This publication has 51 references indexed in Scilit:
- Proinflammatory and Immunoregulatory Roles of Eicosanoids in T CellsFrontiers in Immunology, 2013
- Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A‐RIPK1‐dependent necroptosisEMBO Molecular Medicine, 2012
- Regulation of innate CD8+T-cell activation mediated by cytokinesProceedings of the National Academy of Sciences, 2012
- Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patientsClinical Immunology, 2012
- IL‐33 synergizes with TCR and IL‐12 signaling to promote the effector function of CD8+ T cellsEuropean Journal of Immunology, 2011
- The Sphingosine 1-Phosphate Transporter, SPNS2, Functions as a Transporter of the Phosphorylated Form of the Immunomodulating Agent FTY720Journal of Biological Chemistry, 2011
- Estradiol Induces Export of Sphingosine 1-Phosphate from Breast Cancer Cells via ABCC1 and ABCG2Journal of Biological Chemistry, 2010
- Transcriptional regulation of IL-2 in health and autoimmunityAutoimmunity Reviews, 2009
- IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cellsProceedings of the National Academy of Sciences, 2007
- The PP2A inhibitor SET regulates natural killer cell IFN-γ productionJournal of Experimental Medicine, 2007